Filtered by tag: Pharmacy Remove Filter

The Removal Of The X-Waiver: What It Means For Pain Medicine Practitioners

It is now easier to prescribe buprenorphine to patients with opioid use disorders.

prescription

During the recent State of the Union address, President Joe Biden mentioned a law that simplifies prescribing opioid addiction treatments. He was referring to the X-Waiver, which had been around for over 20 years before it was done away with on December 29, 2022.

“With the signing of the Consolidated Appropriations Act of 2023, Congress eliminated the DATA-Waiver Program,” states the Drug Enforcement Administration (DEA)’s website. “The elimination of the X-Waiver will increase access to buprenorphine for those in need.” 

With the waiver, doctors had to jump through multiple hoops (training, audits, a patient limit) if/when they prescribed the drug. Therefore, as the vice president for research at UT Health San Antonio, Jennifer Potter, told NBC News, health professionals had been waiting for its removal for “years if not a decade or more.”

Read More

CDC rolls out the 2022 Clinical Practice Guideline for Prescribing Opioids for Pain

New guideline provides evidence-based recommendations to help patients and clinicians make informed, patient-centered decisions about effective pain care.

Pain is one of the most common reasons adults seek medical care here in the United States. All patients with pain should receive safe, effective, and informed pain care options. CDC has released a new guideline to support patients and clinicians in reaching their goals for pain care and function.

CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain, which updates and replaces the 2016 CDC Guideline, is a clinical tool to improve communication between clinicians and patients and empower them to make collaborative, individualized, and informed decisions related to pain care. It provides 12 voluntary recommendations for clinicians providing pain care and includes expanded guidance for treatment of acute and subacute pain. The 2022 Clinical Practice Guideline incorporates new evidence to help primary care and other clinicians weigh the risks and benefits of a full range of pain treatment options, including prescription opioids.

The release of the 2022 Clinical Practice Guideline is an important step towards promoting safe and effective pain care. Share and promote the 2022 Clinical Practice Guideline and related resources:

Additional Overdose and Opioid Resources

First Ever National Fentanyl Awareness Day

r National Fentanyl Awareness Day

The first-ever National Fentanyl Awareness Day launches Tuesday, May 10, 2022.

Download Social Media Assets   #NationalFentanylAwarenessDay #FentanylAwareness Download Flyers for your Office 

Visit the National Fentanyl Awareness Day website for more information.You can find additional social media, draft emails to share with partners, key messages, and more using the official toolkit.

Founded by parents who have lost loved ones to the drug overdose epidemic, National Fentanyl Awareness Day is supported by a group of subject matter experts, corporations, nonprofits, schools, families, and elected officials who are coming together to amplify the issue via social media.

Read More

We've gone social!

    LinkedIn     
         
    Twitter    

Be sure to use #TexasPain!

 

#TakeBackDay October 23, 2021

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths. Encourage the gathering of unused, unwanted, or expired prescription drugs to dispose of safely during the upcoming event.

When: Saturday,  October 23, 2021 – 10 AM to 2 PM

Read More

TPS Scientific Conference Hotel Cut Off is TODAY

 Do Not Miss Your Chance!

 

 

Notable Pain Medicine-Specific CME Presentations will focus on the most current research and findings in pain medicine. Earn up to 17 AMA PRA Category 1tm and 2.75 hours of ethics/ professional responsibility in one weekend from distinguished state and national speakers.

 LEARN MORE ABOUT THE EVENT

Get the latest information for your practice!

REGISTER NOW

Read More

NOTICE — Important Changes to PMP Enhancement Funding

NOTICE — Important Changes to
PMP Enhancement Funding

Important changes are coming to the Texas Prescription Monitoring Program (PMP) that will affect integration and NarxCare for certain users.

The funding provided by Senate Bill 500 (86th Texas Legislature) that allowed the Texas State Board of Pharmacy to pay for statewide integration and NarxCare has not been renewed during this most recent legislative session (87th Texas Legislature).

Access to main PMP functionalities will not change. The mandate to check the Texas PMP before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol also remains in effect.

The Texas PMP vendor, Appriss Health, recently sent out a message summarizing these changes to PMP users. 

Read the message from Appriss on our website to learn more and for contact information if you have additional questions. Visit txpmp.org and pharmacy.texas.gov/PMP to learn more about the PMP and to log into your PMP user account.


We're back in person!

Meeting Registration is OPEN!

The Texas Pain Society’s Annual Scientific Meeting is the premier educational conference for pain management physicians in Texas. Each year over 200 physicians attend this one of a kind event.

Notable Pain Medicine-Specific CME Presentations will focus on the most current research and findings in pain medicine. Earn up to 17 AMA PRA Category 1tm and 2.75 hours of ethics/ professional responsibility in one weekend from distinguished state and national speakers.

1. Learn about the latest state law and rule changes from the Texas Medical Board and Texas State Board of Pharmacy and Drug Trafficking at the border

Read More

TMB Emergency Rule Related to Issuance of Prescriptions Renewed for 60 Days

Emergency Rule Related to Issuance of Prescriptions Renewed for 60 Days

 

Texas Physicians and Physician Assistants, the emergency rule related to the issuance of certain prescriptions during the COVID-19 disaster has been renewed for 60 days. 

 

Read More

#TakeBackDay April 24, 2021

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths. Encourage the gathering of unused, unwanted, or expired prescription drugs to dispose of safely during the upcoming event.

When: Saturday,  April 24, 2021 – 10 AM to 2 PM

Read More

3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar on April 23-24, 2021

Dr. Eduardo Bruera, Chair of Palliative, Rehabilitation, and Integrative Medicine, and Dr. Joseph Arthur, (Conference Chair), Associate Professor in Palliative, Rehabilitation, and Integrative Medicine, invite you and your colleagues to join us for this outstanding educational opportunity. We are happy to announce that registration for the 3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar on April 23-24, 2021, is now open.

The 3rd Annual Interdisciplinary Pain and Opioid Crisis Seminar is CME credited for those attending in real-time. Registration is now open and in line with our mission to present accurate data for a global audience.  We hope you will join us for this outstanding educational opportunity.

This will be a great opportunity for all APRNs who attend the conference to earn credit towards their regulatory controlled substance CE requirement.

- REGISTRATION IS NOW AVAILABLE -

Please share the information about this virtual education day with your colleagues.  We look forward to seeing you in April. 

 



Read More

BREAKING NEWS!

Breaking news!

Texas Pain Society is excited to release its very own Continuing Medical Education (CME) courses, courtesy of the Texas Pain Foundation. 

 As part of a TPS membership, CME hours are now available at little or no cost, compliments of Texas Pain Foundation. This is just one of the ways we are working to support our members.

Access our new CME Resource Page HERE

Interested in more free CME and benefits from TPS – consider joining today!

#TakeBackDay this Saturday October 24th

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths. Encourage the gathering of unused, unwanted, or expired prescription drugs to dispose of safely during the upcoming event.

When: Saturday, October 24, 2020 – 10 AM to 2 PM

Read More

DWC Issues Memo on New Telehealth Services

DWC news

New Telehealth Services Available

CMS has issued a new list of telemedicine and telehealth services that can be reimbursed through Medicare during the federally-declared Public Health Emergency for COVID-19. The complete list of covered services is available on the DWC telemedicine page.

Commissioner Brown has issued this memo on the changes.

Read More

Telemedicine for Workers' Compensation

Telemedicine for Worker’s Compensation

Telehealth is a great tool in battling the spread of infections. Texas workers’ compensation allows for billing and reimbursement of certain telemedicine and telehealth services in place of regular on-site medical care. Ask your doctor about services they might provide.

Learn more on the TDI website.

Texas Pain Society Emeritus Board Member, C.M. Schade, MD, PhD, PE Elected Presiding Officer of the Prescription Monitoring Program Advisory Committee.

Texas Pain Society Emeritus Board Member, C.M. Schade, MD, PhD, PE 

Elected Presiding Officer of the Prescription Monitoring Program Advisory Committee.

January 15, 2020

Read More

TPS E- News | Deadline to Dispute Your Sunshine Data is 12/31/2019

Open Payments: Review and Dispute Data by December 31

On June 28, CMS published program year 2018 Open Payments data along with updated and newly submitted data from previous program years (2013-2017). This data is available for review and dispute through December 31. 

Physicians and teaching hospitals: Review of the data is voluntary but strongly encouraged. Use the Open Payments Search Tool to review publicly available data. If you believe any records attributed to you are inaccurate, you may initiate a dispute and work with the reporting entity to reach a resolution. Note: CMS does not mediate disputes.

Read More

Research Group Releases Pharmacy Formulary Report

analysis of injured employee outcomes after the texas pharmacy closed formulary

Research Group Releases Pharmacy Formulary Report

The Research and Evaluation Group has released a report on Texas pharmacy closed formulary outcomes. This study looks at injured employee outcomes such as return-to-work rates and health outcomes since the formulary was implemented.

Need just the key findings? Check the TDI website for our new snapshot tool on the pharmacy formulary report.

Read More

TPS & TSA Pain Education Partnership Success

September 6, 2019 marked another successful year of partnership between Texas Pain Society & Texas Society of Anesthesiologist!

Each year TPS presents a 3 hour parallel session regarding pain medicine during the TSA Annual Conference.

This year we had Drs. Max Eckmann, C.M. Schade and Dhanalakshmi Koyyalagunta, MD representing TPS and an interactive crowd that was very engaged in the current standards and best practices for treating chronic pain patients. 

Read More

PDMP Statutes and Regulations: Compilation by Topic

Image result for pdmp ttac

The PDMP Training and Technical Assistance Center (TTAC) continuously strives to keep prescription drug monitoring programs (PDMPs) and other stakeholders informed and current on the issues that concern and impact PDMPs. Legislative and regulatory change is an area TTAC monitors in order to provide an in-depth overview of PDMPs across the United States. TTAC has compiled a complete listing of all state PDMP statutes and regulations. The report is broken down by topic area (e.g., data transmitters, authorized recipients, mandatory query provisions) for each state, territory, and jurisdiction with a PDMP. The information in the report is based on the statutes and regulations in each jurisdiction and every effort has been made to ensure its accuracy. TTAC will strive to keep the information current with routine updates. The statutory and regulatory citations included in the report are current through June 30, 2019. A copy of the report can be found here: Statutes and Regulations.